l&r medical uk ltd.
l&r medical uk ltd. Company Information
Company Number
03631028
Next Accounts
Sep 2025
Shareholders
l & r gmbh
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
1 wellington court, lancaster park, needwood, burton on trent, DE13 9PS
l&r medical uk ltd. Estimated Valuation
Pomanda estimates the enterprise value of L&R MEDICAL UK LTD. at £34.3m based on a Turnover of £30.7m and 1.12x industry multiple (adjusted for size and gross margin).
l&r medical uk ltd. Estimated Valuation
Pomanda estimates the enterprise value of L&R MEDICAL UK LTD. at £50.4m based on an EBITDA of £4.5m and a 11.28x industry multiple (adjusted for size and gross margin).
l&r medical uk ltd. Estimated Valuation
Pomanda estimates the enterprise value of L&R MEDICAL UK LTD. at £35.5m based on Net Assets of £18.5m and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
L&r Medical Uk Ltd. Overview
L&r Medical Uk Ltd. is a live company located in needwood, DE13 9PS with a Companies House number of 03631028. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in September 1998, it's largest shareholder is l & r gmbh with a 100% stake. L&r Medical Uk Ltd. is a mature, large sized company, Pomanda has estimated its turnover at £30.7m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
L&r Medical Uk Ltd. Health Check
Pomanda's financial health check has awarded L&R Medical Uk Ltd. a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 4 areas for improvement. Company Health Check FAQs
7 Strong
1 Regular
4 Weak
Size
annual sales of £30.7m, make it larger than the average company (£24.5m)
£30.7m - L&r Medical Uk Ltd.
£24.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (5.3%)
4% - L&r Medical Uk Ltd.
5.3% - Industry AVG
Production
with a gross margin of 50.4%, this company has a lower cost of product (29.5%)
50.4% - L&r Medical Uk Ltd.
29.5% - Industry AVG
Profitability
an operating margin of 14.2% make it more profitable than the average company (4.1%)
14.2% - L&r Medical Uk Ltd.
4.1% - Industry AVG
Employees
with 93 employees, this is above the industry average (36)
93 - L&r Medical Uk Ltd.
36 - Industry AVG
Pay Structure
on an average salary of £69.4k, the company has an equivalent pay structure (£81.2k)
£69.4k - L&r Medical Uk Ltd.
£81.2k - Industry AVG
Efficiency
resulting in sales per employee of £329.8k, this is less efficient (£657.9k)
£329.8k - L&r Medical Uk Ltd.
£657.9k - Industry AVG
Debtor Days
it gets paid by customers after 46 days, this is earlier than average (58 days)
46 days - L&r Medical Uk Ltd.
58 days - Industry AVG
Creditor Days
its suppliers are paid after 25 days, this is quicker than average (29 days)
25 days - L&r Medical Uk Ltd.
29 days - Industry AVG
Stock Days
it holds stock equivalent to 106 days, this is more than average (65 days)
106 days - L&r Medical Uk Ltd.
65 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 71 weeks, this is more cash available to meet short term requirements (11 weeks)
71 weeks - L&r Medical Uk Ltd.
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19.7%, this is a lower level of debt than the average (54.6%)
19.7% - L&r Medical Uk Ltd.
54.6% - Industry AVG
L&R MEDICAL UK LTD. financials
L&R Medical Uk Ltd.'s latest turnover from December 2023 is £30.7 million and the company has net assets of £18.5 million. According to their latest financial statements, L&R Medical Uk Ltd. has 93 employees and maintains cash reserves of £6.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 30,672,000 | 28,693,000 | 26,240,000 | 27,313,000 | 25,984,000 | 25,160,000 | 25,207,000 | 24,151,000 | 21,920,000 | 20,167,000 | 18,512,529 | 17,685,196 | 16,481,125 | 15,284,962 | 13,804,793 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 15,224,000 | 12,502,000 | 10,635,000 | 12,806,000 | 11,319,000 | 10,261,000 | 10,108,000 | 8,947,000 | 7,906,000 | 7,232,000 | 6,697,991 | 6,353,579 | 6,028,092 | 5,814,567 | 5,699,511 |
| Gross Profit | 15,448,000 | 16,191,000 | 15,605,000 | 14,507,000 | 14,665,000 | 14,899,000 | 15,099,000 | 15,204,000 | 14,014,000 | 12,935,000 | 11,814,538 | 11,331,617 | 10,453,033 | 9,470,395 | 8,105,282 |
| Admin Expenses | 11,096,000 | 9,530,000 | 8,613,000 | 8,626,000 | 10,681,000 | 10,710,000 | 10,829,000 | 10,738,000 | 10,387,000 | 9,130,000 | 8,293,818 | 8,030,767 | 7,438,260 | 7,224,560 | 5,861,384 |
| Operating Profit | 4,352,000 | 6,661,000 | 6,992,000 | 5,881,000 | 3,984,000 | 4,189,000 | 4,270,000 | 4,466,000 | 3,627,000 | 3,805,000 | 3,520,720 | 3,300,850 | 3,014,773 | 2,245,835 | 2,243,898 |
| Interest Payable | 275 | 1,894 | 19,264 | ||||||||||||
| Interest Receivable | 290,000 | 152,000 | 52,000 | 44,000 | 47,000 | 18,000 | 18,000 | 9,000 | 40,000 | 28,000 | 12,526 | 20,543 | 6,249 | 3,666 | 4,436 |
| Pre-Tax Profit | 4,642,000 | 6,813,000 | 7,044,000 | 5,925,000 | 4,031,000 | 4,207,000 | 4,288,000 | 4,475,000 | 3,839,000 | 3,833,000 | 3,533,246 | 3,321,393 | 3,020,747 | 2,247,607 | 2,229,070 |
| Tax | -1,024,000 | -1,298,000 | -1,328,000 | -1,119,000 | -766,000 | -864,000 | -861,000 | -763,000 | -743,000 | -855,000 | -826,512 | -829,000 | -821,334 | -651,049 | -650,000 |
| Profit After Tax | 3,618,000 | 5,515,000 | 5,716,000 | 4,806,000 | 3,265,000 | 3,343,000 | 3,427,000 | 3,712,000 | 3,096,000 | 2,978,000 | 2,706,734 | 2,492,393 | 2,199,413 | 1,596,558 | 1,579,070 |
| Dividends Paid | 5,000,000 | 4,000,000 | 8,000,000 | 1,000,000 | 4,000,000 | 3,000,000 | 4,000,000 | 2,000,000 | 1,500,000 | ||||||
| Retained Profit | -1,382,000 | 1,515,000 | -2,284,000 | 4,806,000 | 3,265,000 | 2,343,000 | -573,000 | 712,000 | -904,000 | 2,978,000 | 2,706,734 | 492,393 | 699,413 | 1,596,558 | 1,579,070 |
| Employee Costs | 6,458,000 | 5,696,000 | 5,075,000 | 5,921,000 | 6,295,000 | 6,160,000 | 6,149,000 | 6,137,000 | 5,895,000 | 5,494,000 | 5,079,829 | 4,727,000 | 4,278,203 | 4,249,539 | 3,135,460 |
| Number Of Employees | 93 | 88 | 85 | 103 | 110 | 115 | 119 | 129 | 116 | 110 | 110 | 104 | 95 | 91 | 83 |
| EBITDA* | 4,467,000 | 6,776,000 | 7,122,000 | 6,031,000 | 4,167,000 | 4,387,000 | 4,520,000 | 4,678,000 | 3,807,000 | 3,889,000 | 3,592,197 | 3,404,574 | 3,134,979 | 2,354,712 | 2,330,861 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 3,079,000 | 3,150,000 | 3,161,000 | 3,270,000 | 3,369,000 | 3,439,000 | 3,572,000 | 3,616,000 | 2,465,000 | 1,590,000 | 1,115,302 | 682,198 | 736,364 | 791,049 | 548,899 |
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 3,079,000 | 3,150,000 | 3,161,000 | 3,270,000 | 3,369,000 | 3,439,000 | 3,572,000 | 3,616,000 | 2,465,000 | 1,590,000 | 1,115,302 | 682,198 | 736,364 | 791,049 | 548,899 |
| Stock & work in progress | 4,447,000 | 3,647,000 | 3,551,000 | 2,789,000 | 2,729,000 | 1,896,000 | 1,604,000 | 1,941,000 | 1,479,000 | 1,316,000 | 1,236,711 | 852,926 | 967,024 | 905,354 | 1,154,280 |
| Trade Debtors | 3,870,000 | 4,697,000 | 4,201,000 | 3,666,000 | 3,892,000 | 5,145,000 | 5,624,000 | 5,124,000 | 4,896,000 | 2,331,000 | 2,870,671 | 1,933,396 | 3,478,708 | 2,775,468 | 2,671,621 |
| Group Debtors | 5,049,000 | 5,015,000 | 5,016,000 | 5,000,000 | 3,000,000 | 2,007,000 | 29,000 | 45,000 | 10,000 | 800,000 | |||||
| Misc Debtors | 388,000 | 242,000 | 247,000 | 194,000 | 280,000 | 189,000 | 142,000 | 71,000 | 109,000 | 107,000 | 107,559 | 107,125 | 58,985 | 28,538 | 31,392 |
| Cash | 6,219,000 | 7,429,000 | 5,491,000 | 8,841,000 | 5,875,000 | 3,152,000 | 2,416,000 | 4,146,000 | 4,857,000 | 7,668,000 | 4,332,306 | 3,635,306 | 1,407,270 | 2,220,976 | 1,003,898 |
| misc current assets | |||||||||||||||
| total current assets | 19,973,000 | 21,030,000 | 18,506,000 | 20,490,000 | 15,776,000 | 12,389,000 | 9,815,000 | 11,327,000 | 11,351,000 | 11,422,000 | 8,547,247 | 6,528,753 | 6,711,987 | 5,930,336 | 4,861,191 |
| total assets | 23,052,000 | 24,180,000 | 21,667,000 | 23,760,000 | 19,145,000 | 15,828,000 | 13,387,000 | 14,943,000 | 13,816,000 | 13,012,000 | 9,662,549 | 7,210,951 | 7,448,351 | 6,721,385 | 5,410,090 |
| Bank overdraft | |||||||||||||||
| Bank loan | 18,182 | 16,960 | |||||||||||||
| Trade Creditors | 1,059,000 | 1,020,000 | 1,215,000 | 861,000 | 801,000 | 439,000 | 1,007,000 | 1,988,000 | 977,000 | 237,000 | 318,381 | 411,256 | 1,041,105 | 1,004,451 | 962,151 |
| Group/Directors Accounts | 2,123,000 | 656,000 | 425,000 | 474,000 | 284,000 | 986,000 | 357,000 | 509,000 | 731,000 | 17,495 | 128,729 | 167,013 | 227,436 | 576,671 | |
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 1,359,000 | 2,611,000 | 1,649,000 | 1,763,000 | 2,204,000 | 1,812,000 | 1,775,000 | 1,625,000 | 1,999,000 | 1,762,000 | 1,291,637 | 1,342,664 | 1,404,324 | 1,300,617 | 1,259,407 |
| total current liabilities | 4,541,000 | 4,287,000 | 3,289,000 | 3,098,000 | 3,289,000 | 3,237,000 | 3,139,000 | 4,122,000 | 3,707,000 | 1,999,000 | 1,627,513 | 1,882,649 | 2,612,442 | 2,550,686 | 2,815,189 |
| loans | 34,203 | 54,963 | |||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 34,203 | 54,963 | |||||||||||||
| total liabilities | 4,541,000 | 4,287,000 | 3,289,000 | 3,098,000 | 3,289,000 | 3,237,000 | 3,139,000 | 4,122,000 | 3,707,000 | 1,999,000 | 1,627,513 | 1,882,649 | 2,612,442 | 2,584,889 | 2,870,152 |
| net assets | 18,511,000 | 19,893,000 | 18,378,000 | 20,662,000 | 15,856,000 | 12,591,000 | 10,248,000 | 10,821,000 | 10,109,000 | 11,013,000 | 8,035,036 | 5,328,302 | 4,835,909 | 4,136,496 | 2,539,938 |
| total shareholders funds | 18,511,000 | 19,893,000 | 18,378,000 | 20,662,000 | 15,856,000 | 12,591,000 | 10,248,000 | 10,821,000 | 10,109,000 | 11,013,000 | 8,035,036 | 5,328,302 | 4,835,909 | 4,136,496 | 2,539,938 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 4,352,000 | 6,661,000 | 6,992,000 | 5,881,000 | 3,984,000 | 4,189,000 | 4,270,000 | 4,466,000 | 3,627,000 | 3,805,000 | 3,520,720 | 3,300,850 | 3,014,773 | 2,245,835 | 2,243,898 |
| Depreciation | 115,000 | 115,000 | 130,000 | 150,000 | 183,000 | 198,000 | 250,000 | 212,000 | 180,000 | 84,000 | 71,477 | 103,724 | 120,206 | 108,877 | 86,963 |
| Amortisation | |||||||||||||||
| Tax | -1,024,000 | -1,298,000 | -1,328,000 | -1,119,000 | -766,000 | -864,000 | -861,000 | -763,000 | -743,000 | -855,000 | -826,512 | -829,000 | -821,334 | -651,049 | -650,000 |
| Stock | 800,000 | 96,000 | 762,000 | 60,000 | 833,000 | 292,000 | -337,000 | 462,000 | 163,000 | 79,289 | 383,785 | -114,098 | 61,670 | -248,926 | 1,154,280 |
| Debtors | -647,000 | 490,000 | 604,000 | 1,688,000 | -169,000 | 1,546,000 | 555,000 | 225,000 | 2,577,000 | -540,230 | 937,709 | -2,297,172 | 1,533,687 | 100,993 | 2,703,013 |
| Creditors | 39,000 | -195,000 | 354,000 | 60,000 | 362,000 | -568,000 | -981,000 | 1,011,000 | 740,000 | -81,381 | -92,875 | -629,849 | 36,654 | 42,300 | 962,151 |
| Accruals and Deferred Income | -1,252,000 | 962,000 | -114,000 | -441,000 | 392,000 | 37,000 | 150,000 | -374,000 | 237,000 | 470,363 | -51,027 | -61,660 | 103,707 | 41,210 | 1,259,407 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | 2,077,000 | 5,659,000 | 4,668,000 | 2,783,000 | 3,491,000 | 1,154,000 | 2,610,000 | 3,865,000 | 1,301,000 | 3,883,923 | 1,300,289 | 4,295,335 | 858,649 | 1,935,106 | 45,126 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | -18,182 | 1,222 | 16,960 | ||||||||||||
| Group/Directors Accounts | 1,467,000 | 231,000 | -49,000 | 190,000 | -702,000 | 629,000 | -152,000 | -222,000 | 731,000 | -17,495 | -111,234 | -38,284 | -60,423 | -349,235 | 576,671 |
| Other Short Term Loans | |||||||||||||||
| Long term loans | -34,203 | -20,760 | 54,963 | ||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 290,000 | 152,000 | 52,000 | 44,000 | 47,000 | 18,000 | 18,000 | 9,000 | 40,000 | 28,000 | 12,526 | 20,543 | 5,974 | 1,772 | -14,828 |
| cash flow from financing | 1,757,000 | 383,000 | 3,000 | 234,000 | -655,000 | 647,000 | -134,000 | -213,000 | 771,000 | 10,469 | -98,708 | -17,741 | -106,834 | -367,001 | 1,594,634 |
| cash and cash equivalents | |||||||||||||||
| cash | -1,210,000 | 1,938,000 | -3,350,000 | 2,966,000 | 2,723,000 | 736,000 | -1,730,000 | -711,000 | -2,811,000 | 3,335,694 | 697,000 | 2,228,036 | -813,706 | 1,217,078 | 1,003,898 |
| overdraft | |||||||||||||||
| change in cash | -1,210,000 | 1,938,000 | -3,350,000 | 2,966,000 | 2,723,000 | 736,000 | -1,730,000 | -711,000 | -2,811,000 | 3,335,694 | 697,000 | 2,228,036 | -813,706 | 1,217,078 | 1,003,898 |
l&r medical uk ltd. Credit Report and Business Information
L&r Medical Uk Ltd. Competitor Analysis
Perform a competitor analysis for l&r medical uk ltd. by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other large companies, companies in DE13 area or any other competitors across 12 key performance metrics.
l&r medical uk ltd. Ownership
L&R MEDICAL UK LTD. group structure
L&R Medical Uk Ltd. has no subsidiary companies.
Ultimate parent company
LOHMANN & RAUSCHER INTERNATIONAL GMBH
#0067826
L & R GMBH
#0068756
2 parents
L&R MEDICAL UK LTD.
03631028
l&r medical uk ltd. directors
L&R Medical Uk Ltd. currently has 4 directors. The longest serving directors include Mr Martin Pohl (Dec 2018) and Dr Klemens Schulz (Jan 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Martin Pohl | United Kingdom | 48 years | Dec 2018 | - | Director |
| Dr Klemens Schulz | United Kingdom | 60 years | Jan 2019 | - | Director |
| Mr Jonathan Browne | England | 57 years | Oct 2020 | - | Director |
| Mr Holger Magdefrau | United Kingdom | 59 years | Dec 2024 | - | Director |
P&L
December 2023turnover
30.7m
+7%
operating profit
4.4m
-35%
gross margin
50.4%
-10.75%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
18.5m
-0.07%
total assets
23.1m
-0.05%
cash
6.2m
-0.16%
net assets
Total assets minus all liabilities
l&r medical uk ltd. company details
company number
03631028
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
September 1998
age
27
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
activa healthcare limited (July 2017)
accountant
-
auditor
HAWSONS
address
1 wellington court, lancaster park, needwood, burton on trent, DE13 9PS
Bank
-
Legal Advisor
-
l&r medical uk ltd. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to l&r medical uk ltd.. Currently there are 4 open charges and 0 have been satisfied in the past.
l&r medical uk ltd. Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for L&R MEDICAL UK LTD.. This can take several minutes, an email will notify you when this has completed.
l&r medical uk ltd. Companies House Filings - See Documents
| date | description | view/download |
|---|
